Financials

  • Market Capitalization 21.65 M
  • Employee 18
  • Founded 2020
  • CEO N/A
  • Website www.tevogen.com
  • Headquarter Delaware, United States
  • FIGI BBG013395405
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.05
Rapporto prezzo/fatturato
-280.95

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4592
ALGS
Aligos Therapeutics, Inc. - Common stock
6.33 USD-0.47%+7.29%+19.43%-35.34%21.93 M USD
4595
VYNE
VYNE Therapeutics Inc. - Common Stock
0.65 USD-1.52%0.00%0.00%-50.76%21.68 M USD
4599
CLRB
Cellectar Biosciences, Inc. - Common Stock
2.69 USD+2.28%+0.37%+16.96%-14.33%21.50 M USD
4602
SKYE
Skye Bioscience, Inc. - Common Stock
0.61 USD-7.58%-15.28%-22.78%-23.75%21.44 M USD

Notizie